Award
Delivery Order #SPE2DR26FQWQ9
Delivery Order for Pharmaceutical Supply to Support Healthcare Programs
Buyer
Defense Logistics Agency
Award Amount
$57,994.83
Ceiling
$57,994.83
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Feb 24, 2026
Identifier
SPE2DR26FQWQ9
NAICS
424210
This delivery order contract was awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical services, under the parent indefinite delivery vehicle contract aimed at supplying essential pharmaceuticals. The contract focuses on procuring a specific pharmaceutical product, Trikafta, a medication used in cystic fibrosis treatment. The award is significant for the agency as it ensures continuity and reliability in the provision of critical healthcare medications, supporting public health initiatives. Scope of work includes the delivery of the specified pharmaceutical within a tightly defined timeline. This award follows a competitive acquisition process under the broader IDV contract for pharmaceutical services, allowing for efficient and effective procurement. The contract timeline is brief with performance scheduled for a one-day period in early 2026, highlighting a prompt delivery requirement within the ongoing multi-year pharmaceutical services agreement.
Description
4570948310!TRIKAFTA 100-50-75 MG/75MG PKT 14S